跳轉至內容
Merck
全部照片(1)

文件

48165

Sigma-Aldrich

壳聚糖 来源于蟹壳

highly viscous

同義詞:

2-氨基-2-脱氧-(1→4)-β-D-葡萄糖吡喃, 聚-(1,4-β-D-葡萄糖吡喃胺)

登入查看組織和合約定價
全部照片(1)

About This Item

CAS號碼:
9012-76-4
MDL號碼:
MFCD00161512
分類程式碼代碼:
12352201
NACRES:
NA.25

生物源

(crab)

形狀

powder

雜質

≤1% insoluble matter

燃燒殘留物

≤2% (as SO4)

損耗

≤12% loss on drying

顏色

yellow

黏度

>400 mPa.s, 1 % in acetic acid(20 °C)

InChI

1S/C56H103N9O39/c1-87-56(86)65-28-38(84)46(19(10-74)96-55(28)104-45-18(9-73)95-49(27(64)37(45)83)97-39-12(3-67)88-47(85)20(57)31(39)77)103-54-26(63)36(82)44(17(8-72)94-54)102-53-25(62)35(81)43(16(7-71)93-53)101-52-24(61)34(80)42(15(6-70)92-52)100-51-23(60)33(79)41(14(5-69)91-51)99-50-22(59)32(78)40(13(4-68)90-50)98-48-21(58)30(76)29(75)11(2-66)89-48/h11-55,66-85H,2-10,57-64H2,1H3,(H,65,86)/t11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30-,31-,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47-,48+,49+,50+,51+,52+,53+,54+,55+/m1/s1

InChI 密鑰

FLASNYPZGWUPSU-SICDJOISSA-N

尋找類似的產品？ 前往 產品比較指南

一般說明

壳聚糖是一种线性氨基多糖，由大约 20％ 的 β1,4-连接的 N-乙酰-D-葡糖胺（GlcNAc）和大约 80％ 的 β1,4-连接的 D-葡糖胺（GlcN）组成，它是由几丁质在热碱中部分脱乙酰化制备的。

應用

壳聚糖是一种生物相容的、抗菌的、可生物降解的聚电解质，具有多种工业和生物医学应用。其化学性质和低毒性使其特别适合作为药物和基因递送系统的组分，以及用于组织工程的可生物降解的膜和支架的开发。

其他說明

为了全面了解我们针对客户研究提供的各种多糖产品，建议您访问我们的碳水化合物分类页面。

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

nwg

閃點（°F）

Not applicable

閃點（°C）

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)

分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Rushita Shah et al.
Polymers, 11(12) (2019-12-19)
The application of polymeric biomaterial scaffolds utilizing crosslinking strategy has become an effective approach in these days. In the present study, the development and characterization of collagen-chitosan hydrogel film has been reported on using dual crosslinking agent's, i.e., tannic acid
Kyriaki G Zinoviadou et al.
Food & function, 3(3), 312-319 (2012-02-03)
Oil-in-water emulsions (10% w/w n-tetradecane) were prepared at pH = 5.7 by using, as surface active agents, electrostatically formed complexes of sodium stearoyl lactylate (SSL) at a concentration of 0.4% (w/w) and chitosan (CH) in a concentration range between 0
Alberto Busilacchi et al.
Carbohydrate polymers, 98(1), 665-676 (2013-08-31)
The idea of using chitosan as a functional delivery aid to support simultaneously PRP, stem cells and growth factors (GF) is associated with the intention to use morphogenic biomaterials to modulate the natural healing sequence in bone and other tissues.
Liming Hu et al.
Nanoscale, 5(8), 3103-3111 (2013-03-22)
Within the past few years, chitosan-based drug delivery vehicles have become some of the most attractive to be studied. In contrast to all other polysaccharides, chitosan has demonstrated its unique characteristics for drug delivery platforms, including its active primary amino
William D Stanish et al.
The Journal of bone and joint surgery. American volume, 95(18), 1640-1650 (2013-09-21)
Microfracture, the standard of care, is recognized to be an incomplete solution for cartilage damage. BST-CarGel, a chitosan-based medical device, is mixed with autologous whole blood and is applied to a microfractured cartilage lesion in which it physically stabilizes the
查看所有相關論文

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務